Jubilant Pharmova Ltd. Conference Calls and Earnings Call Transcripts

Jubilant Pharmova Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
1139.60
2.70%
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that audio recording of Analyst and Investor Conference Call for Audited financial results for the quarter and financial year ended March 31, 2022 held on Friday, May 27, 2022, has been uploaded on the Company''s website. The link to access the audio call recording is: https://www.jubilantpharmova.com/investors/financials/quarterly-results This is for your information and records.
1139.60
2.70%
Conference Call with Jubilant Pharmova Ltd. Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
1139.60
2.70%
Conference Call with Jubilant Pharmova Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
1139.60
2.70%
Conference Call with Jubilant Pharmova Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.
1139.60
2.70%
Conference Call with Jubilant Pharmova Management and Analysts on Q4FY21 Performance and Outlook. Watch the full transcript.
1139.60
2.70%
Conference Call with Jubilant Pharmova Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.
1139.60
2.70%
Conference Call with Jubilant Pharmova Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.
1139.60
2.70%
Conference Call with Jubilant Life Sciences Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
1139.60
2.70%

Conference Call with Jubilant Life Sciences Management and Analysts on Q1FY21 Performance and Outlook. Click on pdf to read the full text transcript. 

1139.60
2.70%

Conference Call with Jubilant Life Sciences Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript

Earnings Calls Podcast on